Research across Parkinson's Disease
Related studies from across the Parkinson's Disease family.
Evaluating the Efficacy of GLP-1 Receptor Agonists in Patients with Parkinson's Disease
GLP-1 medications show no motor benefit for Parkinson's patients
A meta-analysis reveals that GLP-1 receptor agonists provide no significant motor or non-motor benefits for patients with idiopathic Parkins…
New data suggests GLP-1 receptor agonists do not improve movement or non-motor symptoms in people with Parkinson's disease.
Adaptive immune signatures and T cell infiltration characterize pathology in Alzheimer's, Parkinson's, and Lewy Body dementia
Adaptive Immune Signatures Linked to Alzheimer's and Parkinson's Disease
This mini review synthesizes evidence regarding adaptive immune remodeling and T cell responses in neurodegenerative dementias. The authors …
New research highlights how specific immune cell activity may play a role in the progression of Alzheimer's, Parkinson's, and Lewy body deme…
Mammillothalamic tract serves as a reliable anatomical landmark for MRgFUS PTT planning in Parkinson's disease
New MRI landmarks help target Parkinson's disease treatments more accurately
This mini review evaluates MRI techniques for locating pallidothalamic pathways during MRgFUS PTT planning. It concludes that the mammilloth…
Doctors are using a specific brain structure as a reliable landmark to improve the accuracy of targeting Parkinson's disease during treatmen…
rTMS improves motor function in Parkinson's disease, meta-analysis finds moderate effect
Magnetic brain stimulation improves movement in Parkinson's disease patients
This meta-analysis of 457 patients found that repetitive transcranial magnetic stimulation (rTMS) significantly reduces UPDRS-III scores com…
A new review shows that magnetic brain stimulation can improve motor functions and movements for people living with Parkinson's disease.
GLP-1 receptor agonists improve motor function and mood outcomes in patients with Parkinson's disease
GLP-1 medications show promise for Parkinson's disease motor symptoms
This meta-analysis of 850 patients found that GLP-1 receptor agonists significantly improved motor function (SMD -0.21 to -0.32) and mood ou…
New data suggests certain GLP-1 medications may improve movement and mood in people living with Parkinson's disease.
Loon Lens outperforms Catchii for title and abstract screening in Parkinson Disease research
Agentic AI Tools Show Promise for Screening Parkinson Disease Research
This systematic review evaluates the performance of agentic AI tools, specifically Loon Lens and Catchii, for screening titles and abstracts…
New research shows that specific AI tools can help researchers identify relevant studies on Parkinson disease more accurately than other aut…
Resistance training improves quality of life in Parkinson's disease, meta-analysis finds
Resistance training improves quality of life for Parkinson's disease
This meta-analysis found that resistance training improves quality of life in Parkinson's disease compared to control (SMD -0.81, CI -1.45 t…
New data shows that resistance training helps people with Parkinson's disease enjoy a better quality of life compared to no exercise.
Diabetes mellitus acts as a context-dependent modifier of risk and phenotype in neurological disorders
Diabetes May Influence Risk and Progress of Neurological Disorders
This narrative review synthesizes evidence regarding the role of diabetes mellitus (DM) as a disease modifier across various neurological co…
New research suggests that diabetes can change how certain neurological conditions progress, potentially opening doors for new treatment opt…
Transcranial Magnetic Stimulation reduces motor overflow in focal dystonia and improves stroke and cerebral palsy outcomes
TMS Treatment Shows Potential for Reducing Motor Overflow
This systematic review evaluates the effects of transcranial magnetic stimulation (TMS) on various neurological conditions including stroke,…
Transcranial Magnetic Stimulation may help reduce involuntary movements in patients with focal hand dystonia and other neurological conditio…
Sex-specific genetic risk loci and causal proteins in Parkinson's disease
Identifying Sex Specific Genetic Risks and Brain Proteins in Parkinson Disease
A meta-analysis identifies 10 candidate proteins with sex-biased causal links to Parkinson's disease, highlighting GALC and PSMG1 in females…
New research reveals how sex differences influence genetic risks and protein levels in Parkinson's disease to help tailor future treatments.
Ligustilide shows neuroprotective effects across multiple CNS disorders in preclinical models
Ligustilide Shows Potential for Treating Various Brain Disorders
This systematic review of 55 original studies evaluates the neuroprotective potential of ligustilide (LIG) in various neurological condition…
Early research on the compound ligustilide shows potential to protect brain cells from damage caused by stroke, dementia, and other neurolog…
AhR signaling exhibits dual neurotoxic or neuroprotective effects depending on specific ligand types
Gut Health and AhR Signaling Linked to Alzheimer's and Parkinson's
This systematic review examines the role of Aryl hydrocarbon receptor (AhR) signaling in Alzheimer's and Parkinson's disease. The authors co…
New research highlights how different gut-related signals can either harm or protect the brain in conditions like Alzheimer's and Parkinson'…